Clinnovate Health | News & Events
Clinnovate Health partners with medtech and healthcare technology providers to build and commercialise novel integrative diagnostic platforms for various research and clinical applications.
clinnovate health, clinnovatehealth, Medtech and Healthcare Technology Providers, Research, Clinical Applications
page-template-default,page,page-id-16152,ajax_fade,page_not_loaded,,qode-theme-ver-7.9,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

News & Events


First Life Sciences investment from Singapore in Scotland


Clinnovate Health UK Ltd will become the first life sciences company from Singapore to invest in Scotland, when it launches its Genesis Imaging Services (GIS) laboratory in Glasgow tomorrow (Wednesday 29th March).


Scotland looks best for Singapore’s Clinnovate imaging investment


Clinnovate Health offers histology and genomics services for the clinical research market in areas of fibrosis and cancer. The Singapore company will test and develop its kidney imaging system for transplant histological assessment at its laboratory in University of Glasgow’s new Imaging Centre of Excellence opened at Glasgow’s Queen Elizabeth University Hospital.


Positive moves provide shot in arm for life sciences


The launch of the Clinnovate Health laboratory yesterday also marked the first ever investment by a Singaporean firm in the Scottish life sciences sector. Clinnovate provides services for the clinical research market in areas of fibrosis and cancer.


Why invest anywhere else than Scotland?


Inward investment to Scotland secured 7839 jobs in 2016/17 – an increase of 10% on the previous year


Young Company Finance: Clinnovate Health Glasgow based laboratory expanding its research

October 2017

Next this month we look at another of this year’s SMART award winners. Having received £93k to support a feasibility study, Singapore and Scotland based Clinnovate Health is expanding its laboratory work into new fields of medical research.



Scotland and Singapore: Collaborating on the Digital Economy

The Secretary of State for Scotland David Mundell will be in Singapore to highlight these collaborations and identify new areas for Singapore and Scotland to work together in the future. He was joined by a numebr of speakers from Scottish companies and Universities with a presence in Singapore.


We will be having a poster session with NorthSea Therapeutics at the AASLD Liver Meeting 2018 in San Francisco. Come by to find out more!

We are located at  


Location: Moscone Center North/South Building, Hall C

Publication Number: 1300

Poster Title: Icosabutate, a Novel Structurally Engineered Fatty-Acid, Exhibits Potent Anti-Inflammatory and Anti-Fibrotic Effects in a Dietary Mouse Model Resembling Progressive Human Non-Alcoholic Steatohepatitis
Poster Viewing : Saturday, November 10, 2018, 2:00 – 7:00 pm

Presenters Around: 5:30 pm – 7:00 pm